BioCentury

7:00 AM GMT, Jun 4, 2001
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Strategy

The not-for-profit play

Although MDS Proteomics Inc. is in business to discover and develop drug candidates based on knowledge gleaned from proteomics, the company last week set up a not-for-profit organization with IBM Corp. to aggregate protein interaction data from public sources.

While it seems contradictory to give away information on which its business is based, MDS believes that it will be able to

Read the full 600 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.